Skip to content
OpenCapital
Get started

CONMED CNMD Amortization Of Financing Costs

Amortization Of Financing Costs at other companies

LivaNova logo
LivaNovaLIVN
$4.77M-16.0%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's amortization of financing costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's amortization of financing costs?
CONMED (CNMD) reported amortization of financing costs of $1.28M in Q1 2026.
How has CONMED's amortization of financing costs changed year-over-year?
CONMED's amortization of financing costs decreased by 11.6% year-over-year, from $1.44M to $1.28M.
What is the long-term trend for CONMED's amortization of financing costs?
Over 4 years (2021 to 2025), CONMED's amortization of financing costs has grown at a 10.9% compound annual growth rate (CAGR), from $3.73M to $5.65M.
What does amortization of financing costs mean?
The periodic expense recognized from the systematic allocation of costs incurred to obtain debt financing over the life of the related debt instrument. It reflects the non-cash cost of maintaining the company's capital structure and debt facilities.